FORD Daniel James,FRANKLIN Richard Jeremy,GHAWALKAR Anant Ramrao,HORSLEY Helen Tracey,HUANG Qiuya,REUBERSON James Thomas,VANDERHOYDONCK Bart,REUB
申请号：
SI201331080
公开号：
SI2935269T1
申请日:
2013.12.20
申请国别(地区):
SI
年份:
2018
代理人:
摘要：
A series of pyrazolo[3,4-d]pyrimidine derivatives that are substituted at the 4-position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders； viral diseases and malaria； and organ and cell transplant rejection.
